Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

FTXH ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

FTXH Analyst Ratings

Moderate Buy
50ConsensusRatings
48Buy2Hold0Sell
Based on the Wall Street analyst consensus for 50 of FTXH’s holdings.

FTXH 12 Month Forecast

$47.84â–²(8.13% Upside)
Based on Wall Street analyst 12-month price targets for 50 of First Trust Nasdaq Pharmaceuticals ETF’s holdings in the last 3 months. The average price target is $47.84 with a high forecast of $57.03 and a low forecast of $34.81. The average price target represents a 8.13% change from the last price of $44.24.
Highest Price Target$57.03Average Price Target$47.84Lowest Price Target$34.81

FTXH Stocks With Highest Upside Potential

FTXH highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$163.75(101.86% Upside)
Moderate Buy$331.96(101.19% Upside)
Strong Buy$44.14(94.29% Upside)
Strong Buy$109.00(81.97% Upside)
Strong Buy$140.33(70.35% Upside)

FTXH Stocks With Highest Downside Potential

FTXH highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Hold$127.69(-42.41% Downside)
Moderate Buy$105.86(-19.14% Downside)
Hold$57.58(-17.01% Downside)
Moderate Buy$406.71(-12.73% Downside)
Strong Buy$329.85(-8.23% Downside)

FTXH ETF FAQ

What is FTXH’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 50 of FTXH’s holdings, First Trust Nasdaq Pharmaceuticals ETF’s 12-month average price target is $47.84.
What is FTXH’s upside potential, based on the analysts’ average price target?
FTXH’s average price target of $47.84 represents a 8.13% upside from its last price of $44.24.
Is FTXH a Buy, Sell or Hold?
First Trust Nasdaq Pharmaceuticals ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 50 of FTXH’s holdings: 48 rated Buy, 2 rated Hold and 0 rated Sell.
What is First Trust Nasdaq Pharmaceuticals ETF’s price target?
The average price target for First Trust Nasdaq Pharmaceuticals ETF is $47.84, based on Wall Street analyst 12-month price targets for 50 of FTXH’s holdings, issued in the past 3 months. The highest price target is $57.03 and the lowest is $34.81. The average price target represents a 8.13% increase from the last price of $44.24.
What is FTXH’s expense ratio?
FTXH’s expense ratio is 0.60%.
How many holdings does FTXH have?
FTXH holds 51 assets.
How can I buy shares of FTXH?
You can buy shares of FTXH through a brokerage account. Compare brokers on our Best Online Brokers page.